Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Elixinol Wellness ( (AU:EXL) ) has shared an announcement.
Elixinol Wellness Limited has reported that 58,220 performance rights on issue under ASX code EXLAC have lapsed unexercised following their expiry on 15 January 2026. The expiry slightly reduces the company’s pool of potential equity-based instruments on issue, but reflects a routine adjustment to its capital structure rather than a new capital raising or buyback initiative.
The most recent analyst rating on (AU:EXL) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Elixinol Wellness stock, see the AU:EXL Stock Forecast page.
More about Elixinol Wellness
Average Trading Volume: 689,329
Technical Sentiment Signal: Sell
Current Market Cap: A$4.55M
For a thorough assessment of EXL stock, go to TipRanks’ Stock Analysis page.